K&L Consulting Services, a CRO based in Fort Washington, Penn., has selected the OpenClinica Enterprise Edition for Electronic Data Capture (ED”) and clinical data management for phase I-IV clinical trials. K&L is increasing the breadth of its capabilities in the U.S. as well as in Asia and the Pacific region, especially in China.
“We welcome this opportunity to work closely with K&L to help them grow their global practice,” said Ben Baumann, COO at OpenClinica, an open source software company based in Waltham, Mass.
OpenClinica’s commercial open source model stands out in the realm of clinical research software. The company’s strategy is to leverage its rapidly growing global community of users and developers (currently nearly 17,000 people) in order to produce high quality software in a more agile and transparent way for use across the spectrum of clinical research.
“OpenClinica Enterprise allows us to deploy studies quickly and cost effectively, and pass this value on to our clients,” said Dr. Henry Wu, vice president of biostatistics and data management, K&L.
The OpenClinica software is available in two editions: The OpenClinica Community Edition is freely available under a common open source license. The OpenClinica Enterprise Edition pairs the open source technology with a regulatory compliance infrastructure and robust support services.